Stanislav Glezer
Director/Board Member bij Diabetes Foundation of New Jersey
Vermogen: 207 678 $ op 30-04-2024
Actieve functies van Stanislav Glezer
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Diabetes Foundation of New Jersey | Director/Board Member | 24-07-2019 | - |
Loopbaan van Stanislav Glezer
Eerdere bekende functies van Stanislav Glezer
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INOGEN, INC. | Chief Tech/Sci/R&D Officer | 21-06-2021 | 03-05-2024 |
| BECTON, DICKINSON AND COMPANY | Chief Tech/Sci/R&D Officer | 01-09-2018 | 01-06-2021 |
| ADOCIA | Chief Tech/Sci/R&D Officer | 26-07-2017 | 01-05-2018 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Chief Tech/Sci/R&D Officer | 01-03-2016 | 01-03-2017 |
| Sanofi SA | Corporate Officer/Principal | - | - |
Opleiding van Stanislav Glezer
| California Coast University | Masters Business Admin |
| Yevdokimov MSUMD | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
| Frankrijk | 3 |
| Rusland | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 4 |
| Doctorate Degree | 1 |
| Masters Business Admin | 1 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| INOGEN, INC. | Health Technology |
| ADOCIA | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
| Sanofi SA | Health Technology |
| Diabetes Foundation of New Jersey |
- Beurs
- Insiders
- Stanislav Glezer
- Ervaring
